TRANSLATE BIO
Translate Bio is a biotechnology company that in biotechnology, RNA therapeutics, and rare diseases. Translate Bio is a therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
TRANSLATE BIO
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2011-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.translate.bio
Total Employee:
101+
Status:
Closed
Contact:
(617) 945-7361
Total Funding:
442.63 M USD
Technology used in webpage:
SPF Amazon ASP.NET IIS IIS 10 Amazon Ohio Region NameBright Tierpoint
Similar Organizations
10X Genomics
10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.
23andMe
23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Micropep Technologies
Micropep Technologies is a biotech company that focused on biological alternatives to agrochemicals.
Vaxart
Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Current Advisors List
Board_member
Board_member
2017-10-01
Board_member
Board_member
Board_member
2012-09-01
Board_member
2019-01-01
Board_member
2019-04-01
Board_observer
Current Employees Featured
Balkrishen Bhat Vice President Oligonucleotide Therapeutics @ Translate Bio
Vice President Oligonucleotide Therapeutics
Richard Wooster Chief Scientific Officer @ Translate Bio
Chief Scientific Officer
2019-04-01
Founder
Stock Details
Investors List
Omega Funds
Omega Funds investment in Series C - Translate Bio
The Baupost Group
The Baupost Group investment in Series C - Translate Bio
Fidelity
Fidelity investment in Series C - Translate Bio
The Baupost Group
The Baupost Group investment in Series C - Translate Bio
Fidelity
Fidelity investment in Series C - Translate Bio
Atlas Venture
Atlas Venture investment in Series C - Translate Bio
SR One
SR One investment in Series C - Translate Bio
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Translate Bio
Omega Funds
Omega Funds investment in Series C - Translate Bio
Monsanto Growth Ventures (MGV)
Monsanto Growth Ventures (MGV) investment in Series B - Translate Bio
Official Site Inspections
http://www.translate.bio
- Host name: ec2-54-247-151-159.eu-west-1.compute.amazonaws.com
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
Cannot get whois informations of this domain!!!
More informations about "Translate Bio"
Sanofi to Buy Translate Bio, Expanding mRNA Tech | Sanofi
Aug 3, 2005 The foregoing factors should be read in conjunction with the risks and cautionary statements discussed or identified in the public filings with the U.S. Securities and Exchange …See details»
Sanofi completes acquisition of Translate Bio, accelerating the ...
Sep 14, 2013 Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics . PARIS – September 14, 2021 - Sanofi announced …See details»
Translate Bio - Crunchbase Company Profile & Funding
Translate Bio is a biotechnology company that in biotechnology, RNA therapeutics, and rare diseases. Translate Bio is a therapeutics company developing a new class of potentially …See details»
Sanofi completes acquisition of Translate Bio, accelerating the ...
Sep 14, 2021 The tender offer for all of the outstanding shares of Translate Bio common stock expired as scheduled at one minute after 11:59 p.m., Eastern Time, on Monday, September …See details»
Sanofi concludes acquisition of Translate Bio for $3.2bn
Sep 15, 2021 With the acquisition, Translate Bio will continue as a surviving corporation and work as an indirect, fully owned unit of Sanofi. Sanofi and …See details»
With $3.2B, Sanofi takes in mRNA partner Translate Bio …
Aug 3, 2021 With $3.2B, Sanofi takes in mRNA partner Translate Bio in buyout deal. By Nick Paul Taylor Aug 3, 2021 7:50am. COVID-19 Influenza mergers and acquisitions ...See details»
Translate Bio - Funding, Financials, Valuation & Investors
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases. New. Resources. Advanced Search. Start Free Trial . ... How much funding …See details»
Translate Bio - VentureRadar
Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. …See details»
Translate Bio, Inc. (Translate Bio, Inc.) - 药物管线_专利_ …
了解Translate Bio, Inc. (Translate Bio, Inc.)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 73篇新闻和3篇文献，疾病领域:感染，技术平台:预防性疫苗，mRNA疫苗，药物:Bacterial infection mRNA vaccine (Translate …See details»
Translate Bio, A Sanofi Company - ContactOut
Translate Bio | 7,119 followers on LinkedIn | Developing potentially transformative mRNA therapeutics for rare, genetic diseases | Translate Bio is a leading mRNA therapeutics …See details»
Sanofi finalise l’acquisition de Translate Bio et accélère le ...
Sep 14, 2013 Sanofi annonce aujourd’hui la finalisation de l’acquisition de Translate Bio, une opération qui donne un nouveau coup d’accélérateur aux initiatives que l’entreprise a …See details»
TiPLab - mRNA疗法开发公司：Translate Bio
Translate Bio是一家新兴的mRNA疗法的公司，致力于将mRNA转化为治疗性药物，实现mRNA的治疗潜力。 Translate Bio总部位于美国马萨诸塞州，于2016年11月以RaNA Therapeutics的 …See details»
Translate Bio (Lexington, MA, USA) ー元製薬研究員ケンのバイオ …
Oct 5, 2019 Translation BioではLNPを用いている。 LNPは静脈内投与すると肝臓などの特定の臓器に指向性があるため、適応できる疾患が限定される。 肺への投与の場合は吸入、眼へ …See details»
Translate Bio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Mar 2, 2025 Organization. Translate Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Total Products Active …See details»
FDA puts Translate Bio’s rare disease mRNA drug on hold
Jan 22, 2019 The last time Translate Bio ran into a clinical hold, it resolved the issue in four months. After placing the hold on MRT5005, the cystic fibrosis program, in December 2017, …See details»
Translate Bio-Translate Bio, Inc.-企业详情-InvestGO数据库-ByDrug …
Dec 31, 2010 查看医药魔方InvestGO®数据库Translate Bio的公司信息。Translate Bio（Translate Bio, Inc.），公司简介：Translate Bio is a biotechnology company that …See details»
Sanofi and Translate Bio initiate Phase 1 clinical trial of mRNA ...
Jun 22, 2005 About Translate Bio Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by …See details»
Translate Bio Announces Results from Second Interim Data
Mar 17, 2021 Contacts for Translate Bio. Investors Teri Dahlman tdahlman@translate.bio 617-817-8655. Media Maura Gavaghan mgavaghan@translate.bio 617-233-1154. Tags TBIO …See details»
信使RNA疗法公司：Translate Bio, Inc. (TBIO) | 美股之家
Nov 4, 2018 Translate Bio公司的MRT平台在过去十年持续在开发，最初在Shire Human Genetic Therapies, Inc.并自2016年起在Translate Bio内部进行开发。随着MRT的科学创始人现在成 …See details»
Biography Translator - Anything Translate
With the Biography Translator, transforming your normal language into captivating biographies has never been easier! This innovative tool expertly crafts the essence of your life, …See details»